. 2014 Apr 15;52(5):2869–2877. doi: 10.1007/s13197-014-1351-5

Table 2.

Values of fatty acids, cholesterol content and TBA in the experimental treatments

Treatments	Fatty acids (%)		Cholesterol (mg/100 g)	TBARS (mg MDA/kg)
Treatments	Saturated	Polyunsaturated	Cholesterol (mg/100 g)	TBARS (mg MDA/kg)
T1	29.70ª (±1.64)	69.78ª (±1.72)	65.37ª (±12.90)	0.34^a (±0.19)
T2	28.85ª (±2.08)	70.64ª (±1.68)	74.70ª (±7.68)	0.24^a (±0.10)
T3	28.63ª (±1.25)	70.31ª (±1.61)	65.04ª (±7.58)	0.23^a (±0.06)
T4	28.31ª (±1.48)	71.26ª (±1.26)	70.74ª (±8.67)	0.20^a (±0.10)
T5	30.57ª (±3.07)	68.94ª (±3.13)	76.84ª (±7.97)	0.22^a (±0.10)
Overall mean	29.21 (±1.97)	70.19 (±1.94)	70.54 (±9.69)	0.25 (±0.19)

Results are the mean ± standard deviation. The means followed by the same lowercase letters in the columns comparing fatty acids, cholesterol and TBA among treatments do not differ according to Tukey’s test (p > 0.05)

T1 1 % transglutaminase; T2 1 % transglutaminase and 15 % MSCM; T3 1 % egg albumin powder; T4 1 % egg albumin powder and 15 % MSCM; T5 1 % transglutaminase, 1 % egg albumin powder and 15 % MSCM